Trials / Sponsors / Nina Bhardwaj
Nina Bhardwaj
Academic / Other · 7 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | Pembrolizumab Effects on NK Cell Exhaustion in Melanoma (Merck NK-IIT) Melanoma | Phase 2 | 2017-12-20 |
| Completed | Safety and Immunogenicity of Personalized Genomic Vaccine to Treat Malignancies Solid Tumors | Phase 1 | 2016-04-01 |
| Completed | A Comparison of Matured Dendritic Cells and Montanide® in Study Subjects With High Risk of Melanoma Recurrence Melanoma | Phase 2 | 2015-07-01 |
| Completed | Enhancement by Poly-ICLC During HIV-1 Infection HIV-1 Infected Adults With Chronic HIV-1 Infection | Phase 1 / Phase 2 | 2014-04-01 |
| Terminated | Treatment of Solid Tumors With Intratumoral Hiltonol® (Poly-ICLC) Melanoma, Squamous Cell Carcinoma of the Head and Neck, Squamous Cell Carcinoma of the Skin | Phase 2 | 2013-11-01 |
| Completed | Safety Study of Adjuvant Vaccine to Treat Melanoma Patients Melanoma | Phase 1 / Phase 2 | 2010-09-01 |
| Completed | Randomized, Double Blind, Placebo-controlled Topical Resiquimod Adjuvant for NY-ESO-1 Protein Vaccination Tumors | Phase 1 | 2009-02-01 |